Xianyong Bai

Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice

Fangfang Yang, Jingmin Li, Jin‐Hui Zhu et al. · European Journal of Pharmacology · 2015 · 98 citations

A Inhibits Angiogenesis, Medicine, Liver Physiology +10

Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress

Chuhui Wang, Q. Liu, Qingxian Huang et al. · Phytomedicine · 2013 · 66 citations

Inflammation, Hepatology, Biochemistry +11

Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation

Jingyu Zhang, Jingmin Li, Haoran Song et al. · Biomedicine & Pharmacotherapy · 2018 · 48 citations · Full text

Chemoprevention Strategy, P38 Activation, Immunology +20

Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling

Q. Liu, C. Y. Wang, Z. Liu et al. · Pharmaceutical Biology · 2014 · 43 citations

Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer

Na Wu, Jingmin Li, Hanlin Luo et al. · Biomedicine & Pharmacotherapy · 2021 · 38 citations · Full text